These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


413 related items for PubMed ID: 23124163

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design, synthesis and antimicrobial activities evaluation of Schiff base derived from secnidazole derivatives as potential FabH inhibitors.
    Li Y, Zhao CP, Ma HP, Zhao MY, Xue YR, Wang XM, Zhu HL.
    Bioorg Med Chem; 2013 Jun 01; 21(11):3120-6. PubMed ID: 23602519
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F, Wen Q, Wang SF, Shahla Karim B, Yang YS, Liu JJ, Zhang WM, Zhu HL.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):90-5. PubMed ID: 24332628
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antimicrobial activities of oximes derived from O-benzylhydroxylamine as FabH inhibitors.
    Luo Y, Zhang LR, Hu Y, Zhang S, Fu J, Wang XM, Zhu HL.
    ChemMedChem; 2012 Sep 01; 7(9):1587-93. PubMed ID: 22811397
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC, Sun J, Luo Y, Yang Y, Zhu HL.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4657-60. PubMed ID: 20594840
    [Abstract] [Full Text] [Related]

  • 8. Novel Schiff-base-derived FabH inhibitors with dioxygenated rings as antibiotic agents.
    Zhou Y, Du QR, Sun J, Li JR, Fang F, Li DD, Qian Y, Gong HB, Zhao J, Zhu HL.
    ChemMedChem; 2013 Mar 01; 8(3):433-41. PubMed ID: 23401291
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of 2-styryl of 5-Nitroimidazole derivatives and antimicrobial activities as FabH inhibitors.
    Duan YT, Wang ZC, Sang YL, Tao XX, Teraiya SB, Wang PF, Wen Q, Zhou XJ, Ding L, Yang YH, Zhu HL.
    Eur J Med Chem; 2014 Apr 09; 76():387-96. PubMed ID: 24594526
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC, Wang KR, Yang Y, Mao WJ, Chen J, Xiong J, Zhu HL.
    Bioorg Med Chem Lett; 2009 Dec 01; 19(23):6750-4. PubMed ID: 19836235
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design of Arylsulfonylhydrazones as Potential FabH Inhibitors: Synthesis, Antimicrobial Evaluation and Molecular Docking.
    Fernandes TB, Segretti ND, Lourenço FR, Cândido TM, Baby AR, Barbosa EG, Parise-Filho R.
    Med Chem; 2021 Dec 01; 17(5):474-484. PubMed ID: 31763975
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K, Xue JY, Zhu HL.
    Bioorg Med Chem Lett; 2013 Jul 15; 23(14):4235-8. PubMed ID: 23731945
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF, Yin Y, Wu X, Qiao F, Sha S, Lv PC, Zhao J, Zhu HL.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5727-37. PubMed ID: 25306465
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.